SynBioBeta Speaker
Kid Parchariyanon
SeaX Ventures
Managing Partner
Dr. Kid Parchariyanon, a former physician turned entrepreneur and venture capitalist. He is the Managing Partner of SeaX Ventures, a US-based DeepTech VC fund that invests in exponential technologies globally. SeaX Ventures has backed several Synbio and Life Sciences startups like Hoxton Farms, Bluu Seafood and Cambrium, just to name a few.He is also the CEO and Co-Founder of RISE, one of the largest open innovation platforms in Southeast Asia that partners with corporates and governments to drive 1% of GDP growth while reducing 1% of global carbon emissions. He has supported the launch of more than 2,000 startups, including two unicorns.Dr. Kid is passionate about leveraging technology to solve the world’s biggest challenges, especially in the fields of DeepTech and sustainability. With an MD from Mahidol University and an MS in Biomedical Informatics from Oregon Health and Science University, Dr. Kid has a deep passion and a strong belief in the transformative potential of emerging technologies—such as AI, climate tech and life sciences.He has been recognized as Stanford’s GSB Alumni Catalyst, Gen.T List Honoree, Tatler’s The Futurist, Prestige’s 40 Under 40, and Eisenhower Fellow.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Kid
This Year
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Get a Ticket
Featuring
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Jory Bell
Playground Global
General Partner
Top-tier Silicon Valley investor
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
Jessica Owens
Initiate Ventures
Managing Partner
Venture-studio builder, backing tech-bio moonshots.
•
-
Business of Biology
Investor Roundtable Luncheon
Once a year we put the investors in a room by themselves. No startups. No pitches. No slides. Just the people actually moving capital across biotech and synthetic biology, talking honestly about what they're seeing: what's working, what might be overhyped, and where the real opportunities are right now. It's the conversation you can't have when founders are listening. It's invitation-only and space is limited
Get a Ticket
Featuring
Kid Parchariyanon
SeaX Ventures
Managing Partner
Physician-turned VC backing exponential deeptech and synbio.
Jory Bell
Playground Global
General Partner
Top-tier Silicon Valley investor
David Welch
Synthesis Capital
CSO & Co-founder
Alt-protein scientist-investor, ex-Good Food Institute tech strategist.
Shelby Newsad
Compound
Partner
Scientist-turned-investor funding bold biotech bets.
Jessica Owens
Initiate Ventures
Managing Partner
Venture-studio builder, backing tech-bio moonshots.
Session lineup still growing
Get a Ticket
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Get a Ticket
Featuring
Speaker Coming Soon
